Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
Bristol Myers Squibb, Medic Life Sciences Collaborate on Tumor Target Discovery
Medic will receive upfront payments and will be eligible for additional option payments, as well as future development and regulatory milestone payments.
The 53-gene biomarker signature showed promise in predicting immunotherapy response in high-risk triple-negative and HR-positive breast cancer.
Large Study of Early-Onset Colorectal Cancer Patients IDs Unique, Potentially Actionable Mutations
In younger patients, HER2 mutations were more prevalent in those who had MSI-high/TMB-high tumors, while POLE mutations were more common in MSS/TMB-high tumors, researchers reported at ASCO.
One Biosciences Using Single-Cell Transcriptomics to Understand Cancer Therapy Response, Resistance
Premium
The Institut Curie spinout recently published its single-cell data mining method, which it is applying to collaborations with hospitals and pharmaceuticals.
OmicsEdge, Almaden Genomics Partner on Clinical Trial Data Analysis Service
Under the agreement, OmicsEdge will incorporate Almaden's g.nome platform into its drug discovery service.